Gergo Peter Szekeres

Dr. Gergo Peter Szekeres

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2019 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
GSGergo Peter Szekeres
Gergo Peter Szekeres
Janina KneippJanina Kneipp
Janina Kneipp
The collection of surface-enhanced Raman scattering (SERS) spectra of proteins and other biomolecules in complex biological samples such as animal cells has been achieved with gold nanoparticles that are introduced to the sample. As a model for such a situation, SERS spectra were measured in protein solutions using gold nanoparticles in the absence of aggregating agents, allowing for the free formation of a protein corona. The SERS spectra indicate a varied interaction of the protein molecule with the gold nanoparticles, depending on protein concentration. The concentration-dependent optical properties of the formed agglomerates result in strong variation in SERS enhancement. At protein concentrations that correspond to those inside cells, SERS signals are found to be very low. The results suggest that in living cells the successful collection of SERS spectra must be due to the positioning of the aggregates rather than the crowded biomolecular environment inside the cells. Experiments with DNA suggest the suitability of the applied sample preparation approach for an improved understanding of SERS nanoprobes and nanoparticle-biomolecule interactions in general.

16 April 2021 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
CNChuanxiong Nie
Chuanxiong Nie
PPParia Pouyan
Paria Pouyan
DLDaniel Christian Lauster
Daniel Christian Lauster
JTJakob Trimpert
Jakob Trimpert
YKYannic Kerkhoff
Yannic Kerkhoff
RHRainer Haag
Rainer Haag
Here we report that negatively charged polysulfates can bind to the spike protein of SARS‐CoV‐2 via electrostatic interactions. Using a plaque reduction assay, we compare inhibition of SARS‐CoV‐2 by heparin, pentosan sulfate, linear polyglycerol sulfate (LPGS) and hyperbranched polyglycerol sulfate (HPGS). Highly sulfated LPGS is the optimal inhibitor, with an IC50 of 67 μg mL−1 (approx. 1.6 μm). This synthetic polysulfate exhibits more than 60‐fold higher virus inhibitory activity than heparin (IC50: 4084 μg mL−1), along with much lower anticoagulant activity. Furthermore, in molecular dynamics simulations, we verified that LPGS can bind more strongly to the spike protein than heparin, and that LPGS can interact even more with the spike protein of the new N501Y and E484K variants. Our study demonstrates that the entry of SARS‐CoV‐2 into host cells can be blocked via electrostatic interactions, therefore LPGS can serve as a blueprint for the design of novel viral inhibitors of SARS‐CoV‐2.

6 November 2018 in The Analyst
Verified
Journal Article
Closed access
PDF file
GSGergo Peter Szekeres
Gergo Peter Szekeres
Janina KneippJanina Kneipp
Janina Kneipp
The interaction of bovine serum albumin (BSA) and human serum albumin (HSA), sharing a sequence similarity of 77.5%, with gold nanoparticles of a size of ∼30 nm was investigated by surface-enhanced Raman scattering (SERS). The spectra provide information on those residues of the proteins in proximity of the nanoparticles. The SERS signals indicate an electrostatic interaction of both proteins with the citrate ligands at the nanoparticle surface via lysine residues. HSA, different from BSA also binds directly to the gold surface by particularly flexible protein segments that were identified by comparison of the vibrational bands with the known amino acid sequence of the molecule. The data suggest that both the direct binding as well as interaction with the citrate ligands determine the interaction, yet to varying extent in the two very similar serum proteins. This has implications for their use in bio-functionalization, and for the application of gold nanostructures in bioanalytics and medicine.

24 December 2021 in Science Advances
Verified
Journal Article
Open access
RKRichard Karlsson
Richard Karlsson
PCPradeep Chopra
Pradeep Chopra
AJApoorva Joshi
Apoorva Joshi
ZYZhang Yang
Zhang Yang
SVSergey Vakhrushev
Sergey Vakhrushev
RMRebecca L. Miller
Rebecca L. Miller
This study provides proof of concept for cell-based heparin without heparin-induced thrombocytopenia side effects.

17 July 2019 in ACS Nano
Verified
Journal Article
Closed access
VŽVesna Živanović
Vesna Živanović
SSStephan Seifert
Stephan Seifert
DDDaniela Drescher
Daniela Drescher
PSPetra Schrade
Petra Schrade
SWStephan Werner
Stephan Werner
Janina KneippJanina Kneipp
Janina Kneipp